Holen Sie sich die Stockscreener-App
50.82
3.97%
-2.10
Schlusskurs vom Vortag:
$52.92
Offen:
$52.64
24-Stunden-Volumen:
1.99M
Relative Volume:
1.30
Marktkapitalisierung:
$7.70B
Einnahmen:
$3.24B
Nettoeinkommen (Verlust:
$304.90M
KGV:
24.43
EPS:
2.08
Netto-Cashflow:
$156.70M
1W Leistung:
+1.56%
1M Leistung:
-15.40%
6M Leistung:
-21.88%
1J Leistung:
-37.96%
1-Tages-Spanne:
$50.44
$52.92
1-Wochen-Bereich:
$49.29
$54.48
52-Wochen-Spanne:
$48.07
$94.86
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Vergleichen Sie BRKR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
50.82 | 7.70B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-10 | Eingeleitet | UBS | Neutral |
| 2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
| 2024-10-15 | Eingeleitet | Barclays | Overweight |
| 2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Bruker Corporation appoints new board member - Investing.com
Can This New 18,000-Gene Spatial Biology Platform Transform Cancer Research? - StockTitan
Steady Returns Continue: Bruker's Latest Dividend Decision Signals Financial Health - StockTitan
Frank Laukien Buys Handful Of Shares In Bruker - Yahoo Canada Finance
Four Major Healthcare Conferences: Where Bruker Will Share Its 2025 Vision - StockTitan
Bruker corp CEO Frank Laukien buys $1.02m in company stock By Investing.com - Investing.com South Africa
Bruker corp CEO Frank Laukien buys $1.02m in company stock - Investing.com Nigeria
Equities Analysts Set Expectations for Bruker Q1 Earnings - MarketBeat
Bruker (NASDAQ:BRKR) Issues FY 2025 Earnings Guidance - MarketBeat
Bruker Corporation (NASDAQ:BRKR) Q4 2024 Earnings Call Transcript - Insider Monkey
Bruker Co. (NASDAQ:BRKR) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Bruker Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
FY2025 Earnings Estimate for Bruker Issued By Zacks Research - MarketBeat
Bruker (NASDAQ:BRKR) Announces Quarterly Earnings Results - MarketBeat
Glycomics Market Size Expected to Reach USD 8.66 Bn by 2034 - GlobeNewswire Inc.
Bruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls - Yahoo Finance
Bruker Corp (BRKR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Outlook ... - Yahoo Finance
Bruker Corp (BRKR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Outlook ... By GuruFocus - Investing.com Canada
Bruker (NASDAQ:BRKR) Shares Gap Down Following Analyst Downgrade - MarketBeat
Bruker: Q4 Earnings Snapshot - The Washington Post
Bruker Corp Q4 2024 Earnings: EPS of $0.76 Beats Estimates, Reve - GuruFocus.com
Bruker (BRKR) Reports Q4 Earnings: What Key Metrics Have to Say - MSN
Bruker earnings beat by $0.02, revenue topped estimates - Investing.com
Earnings call transcript: Bruker Q4 2024 beats EPS forecast, stock dips - Investing.com
Bruker (BRKR) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Bruker’s (NASDAQ:BRKR) Q4 Sales Top Estimates But Full-Year Sales Guidance Misses Expectations - Yahoo Finance
Bruker reports Q4 earnings beat, issues in-line 2025 guidance By Investing.com - Investing.com South Africa
Bruker reports Q4 earnings beat, issues in-line 2025 guidance - Investing.com
Bruker Corporation Reports Q4 and FY 2024 Financial Results - TradingView
Bruker Earnings Smash Expectations: Q4 Revenue Hits Record $979.6M, Charts Ambitious Growth Path - StockTitan
Bruker Earnings: What To Look For From BRKR - Yahoo Canada Finance
Bruker (NASDAQ:BRKR) Given New $65.00 Price Target at Barclays - Defense World
Bruker Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) - Benzinga
Bruker Spatial Biology promotes Bhaswar Maity - Medical Buyer
Bruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and Webcast - Yahoo Finance
Bruker Q4 2024 Earnings Date Confirmed: Here's When BRKR Reports Critical Year-End Results - StockTitan
Investing in Bruker Corp (BRKR) might be a great opportunity, but the stock is a bit overvalued - US Post News
Bruker Co. (NASDAQ:BRKR) Shares Sold by SG Americas Securities LLC - Defense World
10x, Harvard settle genomics patent dispute with Vizgen during trial - Reuters
Bruker (BRKR) to Report Q4 Results: Wall Street Expects Earnings Growth - MSN
Bruker (BRKR) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
SteelPeak Wealth LLC Has $214,000 Stock Holdings in Bruker Co. (NASDAQ:BRKR) - MarketBeat
Merit Financial Group LLC Makes New Investment in Bruker Co. (NASDAQ:BRKR) - Defense World
Bruker (BRKR) Stock Price, News & Analysis - MarketBeat
CALID Arm Growth to Support Bruker Shares Amid Macro Issues - Yahoo Finance
Spatial Proteomics Market Report and Competitive Landscape 2025-2030, with 10X Genomics, Bruker, Fluidigm, Akoya Biosciences, PerkinElmer, Biotechne, S2 Genomics, Seven Bridges Genomics & More - Yahoo Finance
Park Avenue Securities LLC Has $433,000 Stake in Bruker Co. (NASDAQ:BRKR) - Defense World
Infrared Imaging Microscope | Bruker Optics Inc. | Products - Photonics.com
Leerink Partnrs Issues Positive Estimate for Bruker Earnings - Defense World
Bruker Co. (NASDAQ:BRKR) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Bruker Co. (NASDAQ:BRKR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bruker Corp-Aktie (BRKR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| PACKER RICHARD A | Director |
Dec 02 '24 |
Option Exercise |
19.12 |
10,000 |
191,200 |
84,254 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Sale |
57.82 |
3,350 |
193,683 |
80,904 |
1.16%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):